Tetraphase Pharmaceuticals
Watertown
About Tetraphase Pharmaceuticals
Capitalizing on breakthrough synthetic chemistry, Tetraphase Pharmaceuticals is leveraging a dynamic drug engine targeted at several significant disease categories.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $99.0M
- Funding stage: M&A
- Last round: Grant (Apr 2017)
- Ticker: nasdaq:TTPH
- Website: tphase.com
- Phone: +1 6179263557
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/tetraphase-pharmaceuticals-170578 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.